Black Diamond Therapeutics, Inc vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8.3
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
BDTX
High-quality business with 23% return on equity and 32% profit margins.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $9.86 (+279.1%)
7 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
BDTX
PFE
6.7×
Trailing P/E
19.4×
-2.5×
Forward P/E
9.4×
32.0%
Profit Margin
12.4%
100.0%
Gross Margin
75.8%
22.9%
ROE
8.9%
—
Revenue Growth
-1.2%
—
Earnings Growth
—
3.39
Beta
0.39
—
Price / Book
—
$149M
Market Cap
$149.8B
$1 – $5
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →